| View |
|
DRP-5026-04
|
Guaifenesin + Salbutamol (as Sulfate)
|
Salgee
|
100 mg/ 2 mg
|
Capsule
|
Expectorant / Antiasthma
|
Azarias Pharmaceutical Laboratories, Inc.
|
Philippines
|
Renewal
|
15 December 2023
|
27 December 2028
|
| View |
|
DRP-2836-07
|
Salbutamol + Guaifenesin
|
Salgee
|
1 mg/ 50 mg per 5 mL
|
Syrup
|
-
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
-
|
22 November 2021
|
09 March 2026
|
| View |
|
DRP-3292-01
|
Metformin Hydrochloride
|
Glumet
|
850 mg
|
Film-Coated Tablet
|
-
|
Sydenham Laboratories, Inc.
|
Philippines
|
-
|
10 November 2021
|
03 October 2026
|
| View |
|
DRP-10759
|
Aluminum Hydroxide + Magnesium Hydroxide + Simethicone
|
Magnum-S
|
178 mg / 233 mg / 30 mg
|
Chewable Tablet
|
-
|
Phil. United Pharma Corp. (PUPC)
|
Philippines
|
-
|
16 November 2021
|
16 November 2026
|
| View |
|
HRP-481
|
Hydroquinone + Tretinoin
|
Brilliant Rejuv
|
20mg (2%w/w)/500mcg (0.05%w/w) per gram
|
Topical
Cream
|
Anti-Acne/Depigmenting Agent
|
DJM Grandeur Corporation
|
Philippines
|
Initial
|
12 November 2021
|
12 November 2026
|
| View |
|
HRP-480
|
Hydroquinone + Tretinoin
|
Brilliant Rejuv
|
20 mg (2%w/v)/250 mcg (0.025%w/v)
|
Topical Solution
|
Anti-Acne/Depigmenting Agent.
|
DJM Grandeur Corporation
|
Philippines
|
Initial (Variation)
|
21 February 2024
|
21 February 2029
|
| View |
|
DRP-3442-08
|
Cefuroxime (As Axetil)
|
None
|
500mg
|
Film-Coated Tablet
|
-
|
Interphil Laboratories, Inc.
|
Philippines
|
Initial
|
18 November 2021
|
05 November 2025
|
| View |
|
DRP-3666-05
|
Ciprofloxacin(as hydrochloride)
|
Unbranded
|
500 mg
|
Film Coated Tablet
|
Antibacterial(Fluoroquinolone)
|
Interphil Laboratories Inc.
|
Philippines
|
Renewal
|
29 July 2022
|
10 August 2027
|
| View |
|
DRP-3839-05
|
Irbesartan
|
None
|
150mg
|
Tablet
|
-
|
Interphil Laboratories, Inc.
|
Philippines
|
Initial
|
18 November 2021
|
16 May 2026
|
| View |
|
DRP-10729
|
Metoprolol Tartrate
|
Princicar
|
50 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
12 November 2021
|
19 March 2025
|
| View |
|
DRP-10752
|
Febuxostat
|
Febuxosaph-40
|
40 mg
|
Film-Coated Tablet
|
-
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
-
|
16 November 2021
|
16 November 2026
|
| View |
|
DRP-9995-01
|
Cefalexin (As Monohydrate)
|
Nixin
|
500 mg
|
Capsule
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
22 November 2021
|
14 August 2025
|
| View |
|
DRP-10734
|
Ursodeoxycholic Acid
|
Urdecha
|
250mg
|
Capsule
|
Bile Salt
|
Mepro Pharmaceuticals Private Limited
|
India
|
-
|
18 November 2021
|
21 July 2025
|
| View |
|
DRP-10732
|
Levofloxacin
|
Welquine
|
500 mg / 100 mL (0.5% w/v)
|
Solution for I.V. Infusion
|
Solution for I.V. Infusion
|
Akums Drugs & Pharmaceutical Ltd. (Plant III -
Injectables)
|
India
|
Renewal
|
12 October 2024
|
09 October 2029
|
| View |
|
DRP-5096-04
|
Losartan Potassium
|
None
|
100 mg
|
Film-Coated Tablet
|
-
|
Pascual Laboratories, Inc.
|
Philippines
|
Initial
|
18 November 2021
|
07 December 2025
|
| View |
|
DRP-5095-04
|
Losartan Potassium
|
None
|
50 mg
|
Film-Coated Tablet
|
-
|
Pascual Laboratories, Inc.
|
Philippines
|
Initial
|
18 November 2021
|
07 December 2025
|
| View |
|
DRP-8408-02
|
Metformin Hydrochloride
|
None
|
500 mg
|
Film-Coated Tablet
|
Oral Hypoglycemic Agent (Biguanide)
|
Pascual Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
15 July 2023
|
13 July 2028
|
| View |
|
DRP-395-02
|
Paracetamol + Phenylephrine hydrochloride +
Dextromethorphan hydrobromide
|
Nasatapp® Cough
|
325 mg/25 mg/10 mg
|
Capsule
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
22 November 2021
|
08 June 2025
|
| View |
|
DRP-10728
|
Salbutamol (as sulfate)
|
Salbuline
|
1 mg/mL
|
Nebulizing Solution
|
Anti-asthma
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
05 October 2024
|
29 January 2030
|
| View |
|
DRP-3304-02
|
Erythromycin (As Stearate)
|
None
|
500 mg
|
Tablet
|
-
|
Lumar Pharmaceutical Laboratory, Inc.
|
Philippines
|
-
|
22 November 2021
|
11 October 2026
|